platinum(ii) 1,2-diaminocyclohexane malonate has been researched along with amifostine anhydrous in 1 studies
Studies (platinum(ii) 1,2-diaminocyclohexane malonate) | Trials (platinum(ii) 1,2-diaminocyclohexane malonate) | Recent Studies (post-2010) (platinum(ii) 1,2-diaminocyclohexane malonate) | Studies (amifostine anhydrous) | Trials (amifostine anhydrous) | Recent Studies (post-2010) (amifostine anhydrous) |
---|---|---|---|---|---|
15 | 0 | 0 | 1,636 | 249 | 247 |
Protein | Taxonomy | platinum(ii) 1,2-diaminocyclohexane malonate (IC50) | amifostine anhydrous (IC50) |
---|---|---|---|
D(3) dopamine receptor | Homo sapiens (human) | 1.929 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaney, SG; Holbrook, DJ; Thompson, DC; Wyrick, SD | 1 |
1 other study(ies) available for platinum(ii) 1,2-diaminocyclohexane malonate and amifostine anhydrous
Article | Year |
---|---|
HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
Topics: Amifostine; Antineoplastic Agents; Chromatography, High Pressure Liquid; Magnetic Resonance Spectroscopy; Organoplatinum Compounds; Phosphorus; Radiation-Protective Agents | 1995 |